AI Article Synopsis

  • Nephropathic cystinosis is an autosomal recessive disorder linked to mutations in the CTNS gene affecting lysosomal cystine transport, and this study focuses on the genetic traits specific to Tunisian children with the condition.
  • Researchers analyzed clinical data from 12 Tunisian patients and discovered a new mutation (c.971-1G > C) prevalent in half of the patients, indicating it might be a founder mutation; other mutations were also observed.
  • The findings suggest that mutation patterns in the Tunisian population differ from other regions, highlighting the need for tailored molecular diagnostics and early treatment initiatives in Tunisia.

Article Abstract

Background: Nephropathic cystinosis is an autosomal recessive disease caused by a mutation in the CTNS gene which encodes cystinosin, a lysosomal cystine transporter. The spectrum of mutations in the CTNS gene is not well defined in the North African population. Here, we investigated twelve patients with nephropathic cystinosis belonging to eight Tunisian families in order to analyze the clinical and genetic characteristics of Tunisian children with infantile nephropathic cystinosis.

Methods: Clinical data were collected retrospectively. Molecular analysis of the CTNS gene was performed by Sanger sequencing.

Results: We describe a new splicing mutation c.971-1G > C in the homozygous state in 6/12 patients which seems to be a founder mutation. The reported deletion of 23nt c.771_793 Del (p.Gly258Serfs*30) was detected in a homozygous state in one patient and in a heterozygous compound state with the c.971-1G > C mutation in 3/12 patients. Two of 12 patients have a deletion of exons 4 and 5 of the CTNS gene. None of our patients had the most common 57-kb deletion.

Conclusions: The mutational spectrum in the Tunisian population is different from previously described populations. Thus, a molecular diagnostic strategy must be implemented in Tunisia, by targeting as a priority the common mutations described in this country. Such a strategy will allow a cost-effective diagnosis confirmation as well as early administration of treatment with oral cysteamine. A higher resolution version of the Graphical abstract is available as Supplementary information.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00467-022-05525-1DOI Listing

Publication Analysis

Top Keywords

ctns gene
16
nephropathic cystinosis
12
clinical genetic
8
genetic characteristics
8
characteristics tunisian
8
tunisian children
8
children infantile
8
infantile nephropathic
8
homozygous state
8
patients
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!